✦ LIBER ✦

Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)

✍ Scribed by Tsai, Tsen-Fang; Ho, Ji-Chen; Song, Michael; Szapary, Philippe; Guzzo, Cynthia; Shen, Yuang-Kuang; Li, Shu; Kim, Kwang-Joong; Kim, Tae-Yoon; Choi, Jee-Ho; Youn, Jai-Il

Book ID: 119293760
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 442 KB
Volume: 63
Category: Article
ISSN: 0923-1811
DOI: 10.1016/j.jdermsci.2011.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety results from a phase

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Efficacy and safety of efalizumab in pat

Efficacy and safety of efalizumab in patients with moderate to severe plaque psoriasis*1Pooled results from three phase III randomized, placebo-controlled trials

✍ NAYAK, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 27 KB

Efficacy and safety of systemic treatmen

Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

✍ Schmitt, J.; Rosumeck, S.; Thomaschewski, G.; Sporbeck, B.; Haufe, E.; Nast, A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

A phase III, multicenter, randomized stu

A phase III, multicenter, randomized study comparing ustekinumab and etanercept for the treatment of moderate to severe plaque psoriasis

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Pooled safety and efficacy results from

Pooled safety and efficacy results from two phase III trials comparing briakinumab with etanercept and placebo for the treatment of moderate to severe psoriasis

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety of secukinumab in th

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB